Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Companies
Recent news which mentions Companies
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
30
31
Next >
New Covid vaccines could reach Americans as soon as Thursday – here's what you need to know
September 13, 2023
Tags
Biotechnology
Novavax Inc
Moderna Inc
From
CNBC.com News
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
September 13, 2023
Tags
Health & Science
Pharmaceuticals
Companies
From
CNBC.com News
CDC advisors recommend updated Covid vaccines for all Americans ages 6 months and up
September 12, 2023
Tags
Pharmaceuticals
Health & Science
Companies
From
CNBC.com News
Decongestant found in many cold, allergy medicines doesn’t actually work, FDA advisors say
September 12, 2023
Tags
Health care industry
Breaking news
Business News
From
CNBC.com News
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
September 11, 2023
Tags
Moderna Inc
US: News
Novavax Inc
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Biotechnology
Eli Lilly and Co
US: News
From
CNBC.com News
Carl Icahn says new Illumina CEO has his 'full support' months after proxy fight
September 07, 2023
Tickers
CEOS
Tags
Biotechnology
US: News
Business
From
CNBC.com News
Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial
September 06, 2023
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
September 05, 2023
Tags
Business
Companies
Pharmaceuticals
From
CNBC.com News
Illumina names new CEO months after Icahn proxy fight over Grail deal
September 05, 2023
Tickers
CEOS
Tags
Illumina Inc
Breaking news
Health care industry
From
CNBC.com News
Can you use expired Covid tests? What to know as cases rise, new variants emerge
September 05, 2023
Tags
Business News
COVID/19
Coronavirus
From
CNBC.com News
FTC, Amgen strike deal to allow $27.8 billion Horizon Therapeutics acquisition to move forward
September 01, 2023
Tags
Pharmaceuticals
Health & Science
Companies
From
CNBC.com News
Chinese smartphone maker teases a foldable smartphone that you can wear like a purse
September 01, 2023
Tickers
LIFE
Tags
Apple Inc
Smartphones
Technology: Companies
From
CNBC.com News
Huawei spinoff Honor launches foldable phone globally as Chinese firm looks to rival Apple, Samsung
September 01, 2023
Tags
Companies
Asia Economy
Mobile
From
CNBC.com News
Ozempic could be the next target of Medicare drug price negotiations – here's why
August 31, 2023
Tags
Business News
Medicare health plans
Health care industry
From
CNBC.com News
HHS calls for easing restrictions on marijuana, sending cannabis stocks higher
August 30, 2023
Tags
Biotech and Pharmaceuticals
Canopy Growth Corp
Social issues
From
CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
August 30, 2023
Tags
US: News
Bristol/Myers Squibb Co
Biotechnology
From
CNBC.com News
Here are the three most used drugs on the Medicare price negotiation list
August 29, 2023
Tags
Johnson & Johnson
Business
Health & Science
From
CNBC.com News
Biden administration unveils first 10 drugs subject to Medicare price negotiations as it moves to cut costs
August 29, 2023
Tags
Law and Regulation
Medication
Breaking news
From
CNBC.com News
The ADHD drug market is already stretched thin. Now it's facing a back-to-school supply strain
August 26, 2023
Tags
Teva Pharmaceutical Industries Ltd
Health & Science
Pharmaceuticals
From
CNBC.com News
Wegovy helps reduce heart failure symptoms in obese people, study says
August 25, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Science
From
CNBC.com News
CDC expects new Covid vaccines from Pfizer, Moderna and Novavax to be available in mid-September
August 25, 2023
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Novavax says new Covid vaccine was effective against Eris variant in animal trials
August 22, 2023
Tags
Pfizer Inc
Health care industry
Business News
From
CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
August 21, 2023
Tags
AstraZeneca PLC
Business
Pharmaceuticals
From
CNBC.com News
Teva to pay $225 million in fines and divest generic drug to resolve price-fixing charges
August 21, 2023
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout
August 21, 2023
Tags
Moderna Inc
US: News
Novavax Inc
From
CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
August 21, 2023
Tags
CVS Health Corp
Business
Health & Science
From
CNBC.com News
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
August 18, 2023
Tags
Moderna Inc
US: News
Biotechnology
From
CNBC.com News
Moderna says new Covid vaccine was effective against Eris variant in early trial
August 17, 2023
Tags
Biotech and Pharmaceuticals
Science
Pfizer Inc
From
CNBC.com News
Weight loss drugs are priced substantially higher in the U.S. than in other countries, analysis says
August 17, 2023
Tags
Eli Lilly and Co
Biotechnology
US: News
From
CNBC.com News
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.